Artera was founded in 2021 by Andre Esteva. The company has not publicly endorsed plans to participate in an IPO.

Artera is the developer of AI-powered predictive and prognostic cancer tests. The company's flagship product, the ArteraAI Prostate test, aims to predict the benefits of therapy for patients with localized prostate cancer. As of the public launch in March 2023, Artera had raised $90 million in venture capital funding from investors including Coatue, Johnson & Johnson Innovation, Koch Disruptive Technologies, Walden Catalyst Ventures, TIME Ventures, Breyer Capital, and Marc Benioff. Artera did not disclose valuation figures at the time of launch.

These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Register for Details

For more details on financing and valuation for ArteraAI, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about ArteraAI

Forge green plus iconForge green minus icon

What is ArteraAI's IPO price?

The IPO price for ArteraAI will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in ArteraAI?

ArteraAI is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell ArteraAI shares pre-IPO?

If you own ArteraAI pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is ArteraAI a publicly traded company?

ArteraAI is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is ArteraAI's funding to date?

ArteraAI has raised $89.5MM to date.
Forge green plus iconForge green minus icon

When was ArteraAI founded?

ArteraAI was founded in 2021.

Who are ArteraAI's major investors?

Koch Disruptive Technologies
Coatue Management
Breyer Capital
Time Ventures
Johnson & Johnson Innovation
Walden Catalyst

ArteraAI Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
4/25/2022 Series Seed-1, Seed-2 and Seed-3 $89.5MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 26, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.